181 related articles for article (PubMed ID: 8290450)
1. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine.
Fong IW
Postgrad Med J; 1993; 69 Suppl 3():S15-7. PubMed ID: 8290450
[TBL] [Abstract][Full Text] [Related]
2. The impact of exit-site care and catheter design on the incidence of catheter-related infections.
Jones LL; Tweedy L; Warady BA
Adv Perit Dial; 1995; 11():302-5. PubMed ID: 8534730
[TBL] [Abstract][Full Text] [Related]
3. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
[TBL] [Abstract][Full Text] [Related]
4. A ten-year single-centre experience in children on chronic peritoneal dialysis--significance of percutaneous placement of peritoneal dialysis catheters.
Aksu N; Yavascan O; Anil M; Kara OD; Erdogan H; Bal A
Nephrol Dial Transplant; 2007 Jul; 22(7):2045-51. PubMed ID: 17438008
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of exit site povidone-iodine ointment in the prevention of early peritoneal dialysis-related infections.
Waite NM; Webster N; Laurel M; Johnson M; Fong IW
Am J Kidney Dis; 1997 May; 29(5):763-8. PubMed ID: 9159313
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
7. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
9. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Betjes MG; van Agteren M
Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
[TBL] [Abstract][Full Text] [Related]
10. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters.
McCann M; Moore ZE
Cochrane Database Syst Rev; 2010 Jan; (1):CD006894. PubMed ID: 20091610
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
[TBL] [Abstract][Full Text] [Related]
12. The comparison of exit-site care with normal saline and povidone-iodine in preventing exit-site infection and peritonitis in children on chronic peritoneal dialysis treatment.
Yavascan O; Anil M; Kara OD; Bal A; Akcan N; Senturk S; Unturk S; Aksu N
Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):931-4. PubMed ID: 21912021
[TBL] [Abstract][Full Text] [Related]
13. Our method of povidone-iodine ointment and gauze dressings reduced catheter-related infection in serious cases.
Fukunaga A; Naritaka H; Fukaya R; Tabuse M; Nakamura T
Dermatology; 2006; 212 Suppl 1():47-52. PubMed ID: 16490975
[TBL] [Abstract][Full Text] [Related]
14. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
[TBL] [Abstract][Full Text] [Related]
15. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality.
Mokrzycki MH; Zhang M; Cohen H; Golestaneh L; Laut JM; Rosenberg SO
Nephrol Dial Transplant; 2006 Apr; 21(4):1024-31. PubMed ID: 16449293
[TBL] [Abstract][Full Text] [Related]
16. Surveillance cultures of tunneled cuffed catheter exit sites in chronic hemodialysis patients are of no benefit.
Rosenbaum D; MacRae JM; Djurdjev O; Levin A; Werb R; Kiaii M
Hemodial Int; 2006 Oct; 10(4):365-70. PubMed ID: 17014513
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of a silver ring in preventing exit-site infections in adult PD patients: results of the SIPROCE Study. Silver ring Prophylaxis of the Catheter Exit Site.
Adv Perit Dial; 1997; 13():227-32. PubMed ID: 9360688
[TBL] [Abstract][Full Text] [Related]
18. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].
Kopriva-Altfahrt G; Moser E; Prokschi A; Kraus B; Kovarik J
Wien Klin Wochenschr; 2005; 117 Suppl 6():73-82. PubMed ID: 16437337
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.
Humar A; Ostromecki A; Direnfeld J; Marshall JC; Lazar N; Houston PC; Boiteau P; Conly JM
Clin Infect Dis; 2000 Oct; 31(4):1001-7. PubMed ID: 11049783
[TBL] [Abstract][Full Text] [Related]
20. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
